CTI's FDA TWO YEAR LEAD IS VERY IMPORTANT!
The push is on BIG TIME for a breast cancer detection breakthrough. With CTI's two year FDA study coming to an end, they will have a huge advantage over others just now entering into the race and beginning their studies. CTI & its partners are gearing-up for the very, very aggressive distribution of their system worldwide. They are wasting no time and will not allow others to delay their goal. (Remember Sutro!)
COII has a great technology and there will be others trying to duplicate it. Here is a good example from the May issue of FamilyCircle, page 74:
Medical News By Gini Kopecky:
The FDA has given permission for a company called OmniCorder Technologies, Inc., to begin marketing a new device that uses space-age technology to detect breast cancer, which causes blood vessels to dilate, increasing blood flow to cancer cells and warming surrounding tissue. The BioScan System uses digital infrared-detector technology and special analyzing software developed, respectively, by Sarath Gunapala, M.D., of NASA's Jet Propulsion Laboratory, and Michael Anbar, M. D., OmniCorder's founding scientist, to detect and record temperature fluctuations as small as .027F. The hope is that this device will enable doctors to catch breast cancer long before it would otherwise be found. The results of a preliminary study were encouraging, and the system is now being tested at two university hospitals in New York State."Mammography is still the gold standard in detection, but it has its limitations," says Michael Osborne, M.D., director of the Strang-Cornell Breast Center in New York City and chairman of OmniCorder"s scientific advisory board. "We badly need another test, especially for younger women. "This test is powerful, gives instant results, causes no discomfort, uses no radiation and isn't affected by breast-tissue density, he says,'so it can be used on patients of any age as often as necessary." Says Dr. Gunapala, "It is a pleasure to see something I invented used for public benefit, especially in medicine and even more so in the early detection of cancer." |
